MCI/ PLMCIMG00012 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-PLN | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 1.32 bill.PLN | 2.75% | 9.21 |
GlobeNewswire
06-11
NFI subsidiary Alexander Dennis announces contract with Reading Buses for 53 buses including next-ge...
GlobeNewswire
06-10
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annu...
GlobeNewswire
06-10
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application f...
GlobeNewswire
05-30
L’OCCITANE en Provence and CARBIOS present a PET bottle made from enzymatic recycling, the result of...
GlobeNewswire
05-30
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
05-28
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
05-24
NFI subsidiary Alexander Dennis announces contract with BC Transit for 29 double deck buses
GlobeNewswire
05-23
New Business Volume in Equipment Leasing and Finance Association’s Monthly Leasing and Finance Index...
GlobeNewswire
05-21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
05-20
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI)...
GlobeNewswire
05-17
NFI subsidiary New Flyer announces contract with BC Transit for 33 battery-electric buses
GlobeNewswire
05-15
AVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Lon...
GlobeNewswire
05-15
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire
05-14
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
05-13
New Jersey awards NFI subsidiary New Flyer a contract for up to 1,300 Xcelsior® Transit Buses
GlobeNewswire
05-13
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting ...
GlobeNewswire
05-12
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
05-10
Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsi...
GlobeNewswire
05-09
Investors in Anavex Life Sciences Corporation Should Contact The Gross Law Firm Before May 13, 2024 ...